S
MCRB
Seres Therapeutics Inc
9.27
+0.41+4.63%After Hours: 9.32 +0.05 +0.54%18:50 04/02 EDT
OPEN/PREV CLOSE8.76/8.86
TODAY RANGE8.76-9.34
VOL76.89K
MARKET CAP88.86M
52 WEEK RANGE6.53-29.98
AVG VOL (3M)66.77K
% TURNOVER0.80%
TURNOVER--
P/E (TTM)14.43
% RANGE6.49%
EPS(TTM)0.6422
P/E(FORWARD)-1.1264
P/B2.003
BVPS4.627
DIVIDEND--
P/S112.23
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP78.24M
SHARES OUTSTANDING9.59M
NEXT EARNINGS05/05-05/11
FREE FLOAT8.44M
LOT SIZE1
EX-DATE04/22/2025
News
Press Releases
Financial Reports
Profile
TipRanks·03/16 21:03
Seres Therapeutics Sets 2026 Annual Shareholder Meeting Date
Dow Jones·03/13 18:33
Seres Therapeutics Is Maintained at Buy by Canaccord Genuity
Dow Jones·03/13 18:33
Seres Therapeutics Price Target Maintained With a $22.00/Share by Canaccord Genuity
TipRanks·03/13 11:59
Canaccord Genuity Remains a Buy on Seres Therapeutics (MCRB)
Seeking Alpha·03/12 19:38
Seres Therapeutics GAAP EPS of $0.64, revenue of $0.78M
TipRanks·03/12 12:08
Seres Therapeutics Reports 2025 Results, Highlights Refocused Pipeline
TipRanks·03/12 11:15
Seres Therapeutics reports FY25 EPS 64c
Dow Jones·03/12 11:15
*Seres Therapeutics 2025 EPS 64c >MCRB
Dow Jones·03/12 11:15
*Seres Therapeutics 2025 Rev $789,000 >MCRB
Reuters·03/12 11:14
Seres Therapeutics posts 2025 profit as expenses fall
Benzinga·03/12 11:11
Earnings Scheduled For March 12, 2026
Reuters·03/12 11:00
BRIEF-Seres Therapeutics FY EPS USD 0.64
Barchart·03/12 06:23
Seres Therapeutics: Q4 Earnings Snapshot
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.